Despite recent developments in innovative treatment strategies, stroke remains one of the
leading causes of death and disability worldwide. Stem cell therapy is currently attracting …

Stroke remains a prevalent disease with limited treatment options. Available treatments offer
little in the way of enhancing neurogenesis and recovery. Because of the limitations of …

Background and Purpose—Pilot studies have suggested benefit from intravenous
administration of bone marrow mononuclear stem cells (BMSCs) in stroke. We explored the …

В обзоре описаны основные тенденции и направления персонализированной
медицины. Они включают предсказание на основе геномных данных вероятности …

Cell therapy is emerging as a viable therapy to restore neurological function after stroke.
Many types of stem/progenitor cells from different sources have been explored for their …

Cell therapies are increasingly recognized as a promising option to augment the limited
therapeutic arsenal available to fight ischemic stroke. During the last two decades …

Stroke is a major cause of death and long-term disability, affecting one in six people
worldwide. The only currently available approved pharmacological treatment for ischemic …

Stem cell therapy has been shown to improve stroke outcomes in animal models and is
currently advancing towards clinical practice. However, uncertainty remains regarding the …

Stem cells, renowned for their unique regenerative capabilities, present significant hope in
treating stroke, a major cause of disability globally. This review offers a detailed analysis of …

The goal of this clinical trial was to assess the feasibility and safety of transplanting
autologous bone marrow mononuclear cells into patients suffering severe embolic stroke …